Stock 2931 EUGLENA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Euglena Co., Ltd.

Equities

2931

JP3944370000

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-06-04 am EDT 		5-day change 1st Jan Change
555 JPY 0.00% Intraday chart for Euglena Co., Ltd. +0.73% -20.37%
May. 16 Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended December 31, 2024 CI
Mar. 13 Seiichiro Kametani agreed to acquire Hako inc. from Euglena Co., Ltd. for ¥600 million. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended December 31, 2024
CI
Seiichiro Kametani agreed to acquire Hako inc. from Euglena Co., Ltd. for ¥600 million.
CI
Japanese Shares Track Other Asia Stocks Lower Despite China's Rate Cut
MT
Euglena Slightly Narrows 2023 Attributable Loss as Net Sales Grow
MT
Zenhoren Co.,Ltd. agreed to acquire 18.93% stake in Okinawa Basketball Co., Ltd from Euglena Co., Ltd. for ¥360 million.
CI
KAICO, Ltd. announced that it has received ¥810 million in funding from a group of investors
CI
Euglena Co., Ltd. agreed to acquire Saticine Medical Co., Ltd.
CI
Euglena Co., Ltd. agreed to acquire Japan Beautech Co., Ltd. from Kirei Sozo Holdings, K.K.
CI
Euglena Co., Ltd. entered into stock transfer agreement to acquire Nayuta Co., Ltd. from Kirei Sozo Holdings, K.K. and Hiroji Yamazaki for ¥0.0 million.
CI
Euglena Widens Attributable Loss in Nine Month
MT
Japanese Shares Extend Gains for Sixth Straight Trading Session; Euglena Rises 3%
MT
Euglena Opens Call for Chief Future Officers Under 18 Years Old
MT
Euglena Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Euglena Sees Attributable Loss Fall in FY22
MT
Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending Dec. 31, 2023
CI
Euglena Co., Ltd. announced that it has received ¥7.7999475 billion in funding from Marui Group Co., Ltd., Rohto Pharmaceutical Co.,Ltd., Mazda Motor Corporation, Dai-ichi Life Holdings, Inc.
CI
Euglena Co., Ltd. announced that it expects to receive ¥7.7999475 billion in funding from Marui Group Co., Ltd., Rohto Pharmaceutical Co.,Ltd., Mazda Motor Corporation, Dai-ichi Life Holdings, Inc.
CI
Japanese shares end lower on Fed rate hike worries
RE
Japan's Nikkei inch lower on worries over Fed rate hike impact
RE
Italy's Eni eyes biorefinery in Malaysia with Petronas, Euglena
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2931 Stock
  4. News Euglena Co., Ltd.